{"id":45892,"date":"2022-07-07T05:01:29","date_gmt":"2022-07-07T03:01:29","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\/"},"modified":"2022-07-07T05:01:29","modified_gmt":"2022-07-07T03:01:29","slug":"ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\/","title":{"rendered":"iHealthScreen Inc. is Awarded US Patent on Late Age-related Macular Degeneration (AMD) Prediction Model, which is based on AI and Color Fundus Imaging"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<b>iHealthScreen is the first company that developed the late AMD prediction model and was awarded a patent by USPTO<\/b>\n<\/p>\n<p>NEW YORK&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/AI?src=hash\" target=\"_blank\" rel=\"noopener\">#AI<\/a>&#8212;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fihealthscreen.org%2Fscreening%2F&amp;esheet=52772505&amp;newsitemid=20220706005585&amp;lan=en-US&amp;anchor=iPredictTM&amp;index=1&amp;md5=68383452174b7a10706cd3c1bb63a95e\" rel=\"nofollow noopener\" shape=\"rect\">iPredict<sup>TM<\/sup><\/a> late AMD prediction model provides a fully automated prediction score for age-related macular degeneration (AMD), and identifies the individuals who are at risk of developing late AMD in 1 year, 2-year or 5-year. Earlier the results were published in the top scientific journals. The prediction model can potentially help prevent late AMD and save millions of people from blindness.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220706005585\/en\/1505957\/5\/iHS-logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220706005585\/en\/1505957\/21\/iHS-logo.jpg\"><\/a><\/p>\n<p>\nOnce high-resolution images of the patient\u2019s eyes have been captured using a color fundus camera and submitted to the <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fihealthscreen.org%2Fscreening%2F&amp;esheet=52772505&amp;newsitemid=20220706005585&amp;lan=en-US&amp;anchor=iPredictTM&amp;index=2&amp;md5=51c8e50b4738dc3092025436ea3d70dd\" rel=\"nofollow noopener\" shape=\"rect\">iPredict<sup>TM<\/sup><\/a> AI System, the AMD and prediction results are available in a fully automated report in less than 60 seconds. The entire test can easily and reliably be completed within 5 minutes.\n<\/p>\n<p>\nThe prediction model offers an overall accuracy of 89.61% for identifying an individual at risk of progression to late AMD.\n<\/p>\n<p>\niPredict\u2019s late AMD prediction model can be used as follows:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\niPredict-AMD can detect referable AMD such as intermediate to late AMD and non-referable AMD such as early or none. Once referable AMD is detected, iPredict late AMD prediction model will be utilized and compute the probability score for late AMD.\n<\/li>\n<\/ul>\n<p>\nThe company also has AI-based screening tools for early diagnosis of diabetic retinopathy, AMD and glaucoma which are CE certified and TGA\/Australian health approved.\n<\/p>\n<p>\nIf referable stage disease is detected for any of these conditions, the iPredict automated report recommends a visit to an Ophthalmologist for appropriate treatment. Otherwise, in accordance with standards of care, a follow-up visit in one year is suggested.\n<\/p>\n<p>\niPredict is indicated for use by healthcare providers in clinics, hospitals or other healthcare facilities to automatically detect DR, AMD, and glaucoma suspect.\n<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ihealthscreen.org&amp;esheet=52772505&amp;newsitemid=20220706005585&amp;lan=en-US&amp;anchor=iHealthScreen&amp;index=3&amp;md5=6443d3884c6402740bb5f5a0aa59396b\" rel=\"nofollow noopener\" shape=\"rect\">iHealthScreen<\/a> company is open to partnerships within its products. For more information: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.iHealthScreen.org&amp;esheet=52772505&amp;newsitemid=20220706005585&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.iHealthScreen.org&amp;index=4&amp;md5=bd9f148f1bbbf415323d1e97a1ac2570\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.iHealthScreen.org<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nAlauddin Bhuiyan, Ph.D.<br \/>\n<br \/>CEO, iHealthScreen Inc.<br \/>\n<br \/>E: <a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;&#58;&#x62;h&#x75;i&#x79;a&#x6e;&#64;&#105;&#x68;&#101;&#x61;&#108;&#x74;&#104;&#x73;&#99;&#x72;e&#x65;n&#x2e;o&#x72;g\" rel=\"nofollow noopener\" shape=\"rect\">&#x62;&#x68;&#x75;&#105;&#121;an&#x40;&#x69;&#x68;&#101;&#97;lt&#x68;&#x73;&#x63;&#114;&#101;en&#x2e;&#x6f;&#x72;&#103;<\/a><br \/>T: +1 718 926 9000\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>iHealthScreen is the first company that developed the late AMD prediction model and was awarded a patent by USPTO NEW YORK&#8211;(BUSINESS WIRE)&#8211;#AI&#8212;iPredictTM late AMD prediction model provides a fully automated prediction score for age-related macular degeneration (AMD), and identifies the individuals who are at risk of developing late AMD in 1 year, 2-year or 5-year. &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45892","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>iHealthScreen Inc. is Awarded US Patent on Late Age-related Macular Degeneration (AMD) Prediction Model, which is based on AI and Color Fundus Imaging - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"iHealthScreen Inc. is Awarded US Patent on Late Age-related Macular Degeneration (AMD) Prediction Model, which is based on AI and Color Fundus Imaging - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"iHealthScreen is the first company that developed the late AMD prediction model and was awarded a patent by USPTO NEW YORK&#8211;(BUSINESS WIRE)&#8211;#AI&#8212;iPredictTM late AMD prediction model provides a fully automated prediction score for age-related macular degeneration (AMD), and identifies the individuals who are at risk of developing late AMD in 1 year, 2-year or 5-year. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-07T03:01:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220706005585\/en\/1505957\/21\/iHS-logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"iHealthScreen Inc. is Awarded US Patent on Late Age-related Macular Degeneration (AMD) Prediction Model, which is based on AI and Color Fundus Imaging\",\"datePublished\":\"2022-07-07T03:01:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\\\/\"},\"wordCount\":342,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220706005585\\\/en\\\/1505957\\\/21\\\/iHS-logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\\\/\",\"name\":\"iHealthScreen Inc. is Awarded US Patent on Late Age-related Macular Degeneration (AMD) Prediction Model, which is based on AI and Color Fundus Imaging - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220706005585\\\/en\\\/1505957\\\/21\\\/iHS-logo.jpg\",\"datePublished\":\"2022-07-07T03:01:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220706005585\\\/en\\\/1505957\\\/21\\\/iHS-logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220706005585\\\/en\\\/1505957\\\/21\\\/iHS-logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"iHealthScreen Inc. is Awarded US Patent on Late Age-related Macular Degeneration (AMD) Prediction Model, which is based on AI and Color Fundus Imaging\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"iHealthScreen Inc. is Awarded US Patent on Late Age-related Macular Degeneration (AMD) Prediction Model, which is based on AI and Color Fundus Imaging - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\/","og_locale":"en_US","og_type":"article","og_title":"iHealthScreen Inc. is Awarded US Patent on Late Age-related Macular Degeneration (AMD) Prediction Model, which is based on AI and Color Fundus Imaging - Pharma Trend","og_description":"iHealthScreen is the first company that developed the late AMD prediction model and was awarded a patent by USPTO NEW YORK&#8211;(BUSINESS WIRE)&#8211;#AI&#8212;iPredictTM late AMD prediction model provides a fully automated prediction score for age-related macular degeneration (AMD), and identifies the individuals who are at risk of developing late AMD in 1 year, 2-year or 5-year. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-07T03:01:29+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220706005585\/en\/1505957\/21\/iHS-logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"iHealthScreen Inc. is Awarded US Patent on Late Age-related Macular Degeneration (AMD) Prediction Model, which is based on AI and Color Fundus Imaging","datePublished":"2022-07-07T03:01:29+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\/"},"wordCount":342,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220706005585\/en\/1505957\/21\/iHS-logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\/","url":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\/","name":"iHealthScreen Inc. is Awarded US Patent on Late Age-related Macular Degeneration (AMD) Prediction Model, which is based on AI and Color Fundus Imaging - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220706005585\/en\/1505957\/21\/iHS-logo.jpg","datePublished":"2022-07-07T03:01:29+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220706005585\/en\/1505957\/21\/iHS-logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220706005585\/en\/1505957\/21\/iHS-logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-us-patent-on-late-age-related-macular-degeneration-amd-prediction-model-which-is-based-on-ai-and-color-fundus-imaging\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"iHealthScreen Inc. is Awarded US Patent on Late Age-related Macular Degeneration (AMD) Prediction Model, which is based on AI and Color Fundus Imaging"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45892","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45892"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45892\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45892"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45892"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45892"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}